Adoptive Cell Therapy using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adoptive Cell Therapy using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes, covering 2026-01-08 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors [Phase 1]